| 摘要 |
The present invention relates to a pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing the stem cells which are obtained by adding an NOD2 agonist to stem cells which express NOD2 and culturing the stem cells, or cultured product thereof, and more specifically, to a method for suppressing the immune diseases or inflammatory diseases of a subject, comprising the step of administering the pharmaceutical composition, the stem cell or a cultured product thereof to a subject, a method for preparing an immunosuppressive drug or an anti-inflammatory drug using the stem cells or a cultured product thereof, a method for preparing PGE2 or TGF-ß1, comprising the step of adding an NOD2 agonist to stem cells which express NOD2 and culturing the stem cells, a graft comprising stem cells which express NOD2 and an NOD2 agonist, a preparation method of the graft, a composite comprising stem cells which express NOD2 and an NOD2 agonist, and a cultured product obtained by adding an NOD2 agonist to stem cells which express NOD2. |
